Back
Royalty Pharma PLC Vs. Anavex Life Sciences Industry Stock Comparison
Sell
27
RPRX
Royalty Pharma PLC
Last Price:
26.41
Seasonality Move:
3.06%
Buy
55
AVXL
Anavex Life Sciences
Last Price:
9.09
Seasonality Move:
12.07%
Sell
27
Royalty Pharma PLC (RPRX)
is a Sell
Is Royalty Pharma PLC a Buy, Sell or Hold?
- The current Royalty Pharma PLC [RPRX] share price is $26.43. The Score for RPRX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- RPRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Anavex Life Sciences (AVXL)
is a Buy
Is Anavex Life Sciences a Buy, Sell or Hold?
- The current Anavex Life Sciences [AVXL] share price is $9.11. The Score for AVXL is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- AVXL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RPRX Stock Price Chart
What is Royalty Pharma PLC's stock price today?
-
The Royalty Pharma PLC share price today is $26.43
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RPRX is experiencing slight selling pressure.
AVXL Stock Price Chart
What is Anavex Life Sciences's stock price today?
-
The Anavex Life Sciences share price today is $9.11
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AVXL is experiencing buying pressure, which is a positive indicator for future bullish movement.
RPRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.36 | Sell |
| Relative Strength Index (14 RSI): | 45.67 | Sell |
| Chaikin Money Flow: | -820430 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.05 - 27.31) | Sell |
| Bollinger Bands (100): | (26.56 - 28.44) | Sell |
AVXL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.72 | Buy |
| Relative Strength Index (14 RSI): | 68.53 | Buy |
| Chaikin Money Flow: | 1378097 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.9 - 8.68) | Buy |
| Bollinger Bands (100): | (5.04 - 7.24) | Buy |
RPRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26 | Buy |
| 20-day SMA: | 26.51 | Sell |
| 50-day SMA: | 27.29 | Sell |
| 200-day SMA: | 28.02 | Sell |
| 8-day EMA: | 26.21 | Buy |
| 20-day EMA: | 26.48 | Sell |
| 50-day EMA: | 27.03 | Sell |
| 200-day EMA: | 27.96 | Sell |
AVXL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.33 | Buy |
| 20-day SMA: | 7.76 | Buy |
| 50-day SMA: | 6.39 | Buy |
| 200-day SMA: | 5.3 | Buy |
| 8-day EMA: | 8.49 | Buy |
| 20-day EMA: | 7.81 | Buy |
| 50-day EMA: | 6.85 | Buy |
| 200-day EMA: | 6.01 | Buy |
Royalty Pharma PLC Earnings Growth & RPRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.30 per share, and an increase next year of $0.31 per share.
Anavex Life Sciences Earnings Growth & AVXL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.13 per share.
Royalty Pharma PLC Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Anavex Life Sciences Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||